Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-10-02Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes
-
CLINICAL_TRIALS study record update · 2025-10-02A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Antipsychotic Efficacy of ITI-007 in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-10-02A Randomized, Double-Blind, Placebo- and Active-Controlled, Multi-Center Study to Assess the Antipsychotic Efficacy of ITI-007 After 6 Weeks of Treatment in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-10-01"Culture and Well-being: Art as Prescription Therapy ("Art on Prescription"), Promoting Social Cohesion and Harnessing the "Silver Economy"
-
CLINICAL_TRIALS study record update · 2025-09-30Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-09-30Video Self-observation as a Therapeutic Tool for Improving the Insight of Patients With Schizophrenia Disorders
-
CLINICAL_TRIALS study record update · 2025-09-29A Study on the Efficacy and Functional Recovery of Switching From Oral Antipsychotics to Paliperidone Palmitate Injection in the Treatment of Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-29A Sham-controlled Crossover Study Using Photoneuromodulation to Treatment the Negative Symptoms of Schizophrenia.
-
CLINICAL_TRIALS study record update · 2025-09-25Impact of Cerebellar TMS on Brain and Cognitive Functions in Schizophrenia: a Pilot Study
-
CLINICAL_TRIALS study record update · 2025-09-24Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-23Improving the Assessment and Treatment of Chronic Pain in Veterans With Serious Mental Illness
-
CLINICAL_TRIALS study record update · 2025-09-23Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-22State Representation in Early Psychosis
-
CLINICAL_TRIALS study record update · 2025-09-22Open-label, Flexible-dose Adjunctive Bromocriptine for Patients With Schizophrenia and Prediabetes
-
CLINICAL_TRIALS study record update · 2025-09-19Comparison of the Effects of Aerobic Exercise and Computerized Cognitive Stimulation in Patients With Schizophrenia - A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-09-19Crossover Bioequivalence Study of 12 mg VHX-896 and Iloperidone Tablets Under Steady-State Conditions
-
CLINICAL_TRIALS study record update · 2025-09-19rTMS Add on Value for Amelioration of Negative Symptoms of Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-18Real-time fMRI Neurofeedback as a Tool to Mitigate Auditory Hallucinations in Patients With Schizophrenia - R33 Phase
-
CLINICAL_TRIALS study record update · 2025-09-18Efficacy And Safety of BXCL501 Evaluated For At-Home Use In A Multisite Double-Blind Placebo-Controlled Trial For Agitation Associated With Schizophrenia And Bipolar Disorder
-
CLINICAL_TRIALS study record update · 2025-09-18Horyzons: Implementation and Integration in Clinical Practice
-
CLINICAL_TRIALS study record update · 2025-09-17A Phase 2, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Two Fixed Doses (10 mg and 30 mg QD) of CVL-231 (Emraclidine) in Participants With Schizophrenia Experiencing an Acute Exacerbation of Psychosis
-
CLINICAL_TRIALS study record update · 2025-09-17Sex Differences in NMDA-enhancing Treatment of Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-17An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in De Novo Subjects With DSM-5 Schizophrenia
-
CLINICAL_TRIALS study record update · 2025-09-15The Effect of an Individual Empowerment Program Applied to Primary Caregivers of Patients Diagnosed With Schizophrenia on the Burden of Care, Psychological Well-being, and Self-efficacy: A Randomized Controlled Experimental Study
-
CLINICAL_TRIALS study record update · 2025-09-15Comparison of the Effects of Physical Activity and Virtual Reality Training on Physical Function, Cognition and Quality of Life in Patients With Schizophrenia